http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1056814-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
filingDate 1978-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1979-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71c068402b92610c2db54e80899c1a2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77bff118cb6dcf1283edd09327363e7
publicationDate 1979-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1056814-A
titleOfInvention Formyl-(p-acyloxyphenyl) acetamidocephalosporanic acid derivatives
abstract AsSTRACT OF THE DISCLOSURE This specification discloses certain novel .alpha.-amino- or .alpha.-formyl-.alpha.-(p-acyloxyphenyl)acetamidocephalosporanic acids which are useful as antibacterial agents, and methods of making them. The novel cephalosporin derivatives of this invention comprise the D-(-) compounds of the formula I wherein Y i5 hydrogen or S-Het, in which Het represents a 5 or 6 membered heterocyclic ring containing 1 to 4 atoms selected from N, O or S, said heterocyclic ring being optionally sub-stituted by C1-C4 alkyl which may be optionally substituted by a carboxylic acid group or hydroxy, or alkoxyalkyl of up to 4 carbon atoms; R is hydrogen, C1-C10 alkyl optionally sub-stituted by carboxylic acid, or phenyl optionally substituted by C1-C4 alkyl, halogen, nitro, amino or trifluoromethyl; R' is hydrogen, hydroxy, C1-C4 alkyl, C1-C4 alkoxy or halogen, and pharmaceutically acceptable salts thereof, when substantially free of the L-(+) isomer, and the D-(-) compounds of the formula I(a) I(a) wherein Y is S-Het, in which Het is 1,2,3-triazol-5-yl, 1-N-methyl-tetrazol-5-yl or 2-methyl-1,3,4-thiadiazol-5-yl; R is hydrogen, C1-C10 alkyl optionally substituted by carboxylic -?-acid, or phenyl optionally substituted by C1-C4 alkyl, halo-gen, nitro, amino or trifluoromethyl, R' is hydrogen, hydroxy, C1-C4 alkyl, C1-C4 alkoxy or halogen, ana pharmaceutically acceptable salts thereof, when substantially free of the L-(+) isomer.
priorityDate 1974-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410447510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450961431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12302722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410490416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12048208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414781172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453699109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21448505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409210383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70571329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69066197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451035926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419706572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428244255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24193736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415739975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426101651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452638501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426623464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6410758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457803605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70364644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13050420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420187590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457522556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 75.